Cavenagh, J
Oakervee, H
Baetiong-Caguioa, P
Davies, F
Gharibo, M
Rabin, N
Kurman, M
Novak, B
Shiraishi, N
Nakashima, D
Akinaga, S
Yong, K
Article History
Received: 3 March 2017
Revised: 7 June 2017
Accepted: 8 August 2017
First Online: 5 September 2017
Competing interests
: MK is an employee of Kyowa Kirin Pharmaceutical Development, Inc. (NJ, USA). NS, DN, and SA are employees of Kyowa Hakko Kirin Co. Ltd. KY receives support from the NIHR Biomedical Research Centre (Guy’s and St Thomas’ NHS Foundation Trust and King’s College, London, UK). The remaining authors declare no competing financial interest.